If you thought that heart disease or cancer might be the leading causes of death in England and Wales, you'd be wrong. Dementia has become the leading cause of death and accounted for 12.8% of all deaths in the UK in 2018. It is the biggest health crisis in the UK and has huge financial implications: NHS England and Dementia UK have estimated that the cost associated with the disease is a staggering £23bn per year1. Dementia is an umbrella term used to describe symptoms that occur when the brain cells stop working. This happens when cells die or blood flow in the brain is restricted.

Sina Habibi, CEO of Cognetivity Neurosciences, spoke with INN about the company's partnership with DPUK and additional plans for 2019. At the recent Cantech Investment Conference, Sina Habibi, CEO of Cognetivity Neurosciences (CSE:CGN,OTCQB:CGNSF) spoke with the Investing News Network (INN) about the company's partnership with the Dementia Platform UK (DPUK) and additional plans for 2019. Habibi said the company will be putting more efforts into its artificial intelligence (AI) platform and collecting more data as it seeks to train its solutions to detect mental health disorders, like attention deficit hyperactivity disorder (ADHD). As it currently stands, Cognetivity is using AI and machine learning to aid in the early detection of dementia and Alzheimer's disease. On that note, in addition to the DPUK partnership, Habibi spoke to INN about a health application the company has that could be launched by the end of 2019.